Gabapentin and Blincyto drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Blincyto (blinatumomab). Common drug interactions include arthralgia among females and dry skin among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Blincyto. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,987 Gabapentin users. Check the latest studies of Gabapentin.

What is Blincyto?

Blincyto has active ingredients of blinatumomab. eHealthMe is studying from 6,058 Blincyto users. Check the latest studies of Blincyto.



On Aug, 09, 2026

43 people who take Gabapentin and Blincyto together, and have interactions are studied.

Gabapentin and Blincyto drug interactions.

What are the common drug interactions of Gabapentin and Blincyto, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Cellulitis (infection under the skin)
  3. Dry skin
  4. Overdose
  5. Anaemia (lack of blood)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Blood calcium decreased
  8. Blood creatinine decreased
  9. Blood glucose increased
  10. Cachexia (loss of weight)

male:

  1. Dry skin
  2. Pain in extremity
  3. Palpitations (feelings or sensations that your heart is pounding or racing)
  4. Peripheral swelling
  5. Skin exfoliation (removal of the oldest dead skin cells)
  6. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  7. Drug ineffective
  8. Pyrexia (fever)
  9. Rash
  10. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)

What are the common drug interactions of Gabapentin and Blincyto, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Agitation (state of anxiety or nervous excitement)
  2. Dystonia (abnormal muscle tone)
  3. Emotional distress
  4. Encephalopathy (functioning of the brain is affected by some agent or condition)
  5. Heart rate increased
  6. Hepatomegaly (abnormal enlargement of the liver)
  7. Hyperammonaemia
  8. Lethargy (tiredness)
  9. Neurological decompensation (inability of brain to maintain proper function)
  10. Serum ferritin increased

10-19:

  1. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  3. Drug effect decreased
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Bacterial sepsis
  6. Bone marrow necrosis (death of body tissue of bone marrow)
  7. Drug ineffective
  8. Encephalopathy (functioning of the brain is affected by some agent or condition)
  9. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
  10. Fungal infection

20-29:

  1. Constipation
  2. Lung disorder (lung disease)
  3. Pseudomonal sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas)
  4. Skin hyperpigmentation (disorders affect the colour of your skin)
  5. Urinary tract infection
  6. Abdominal pain
  7. Bone marrow disorder
  8. Bone marrow failure
  9. Disease recurrence
  10. Gait disturbance

30-39:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Chest pain
  3. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  4. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  5. Retinal tear
  6. White blood cell count decreased
  7. Cellulitis (infection under the skin)
  8. Overdose
  9. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  10. Anaemia (lack of blood)

40-49:

  1. Blood calcium decreased
  2. Blood creatinine decreased
  3. Blood glucose increased
  4. Catheter site infection (infection at the site of insertion)
  5. Creatinine renal clearance decreased
  6. Hepatotoxicity (chemical-driven liver damage)
  7. Intervertebral disc protrusion (spinal disc protrusion)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Death
  10. Platelet count decreased

50-59:

  1. Blood bilirubin increased
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Asthenia (weakness)
  6. Blast cell count increased
  7. Blood magnesium decreased
  8. Blood potassium decreased
  9. Blood uric acid increased
  10. Diarrhoea

60+:

  1. Palpitations (feelings or sensations that your heart is pounding or racing)
  2. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Dry skin
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Night sweats (sweating in night)
  7. Nightmare (unpleasant dream)
  8. Pain in extremity
  9. Peripheral swelling
  10. Skin exfoliation (removal of the oldest dead skin cells)

What are the existing conditions these people have? *

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 30 people, 69.77%
  2. Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 6 people, 13.95%
  3. Pain: 5 people, 11.63%
  4. B Precursor Type Acute Leukaemia (lymphoid cancer): 4 people, 9.30%
  5. Pneumonia: 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Blincyto?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gabapentin and Blincyto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Blincyto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Blincyto and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and blinatumomab (the active ingredients of Gabapentin and Blincyto, respectively), and Gabapentin and Blincyto (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: